Anti-PAK6 monoclonal antibody

Pre-made anti-PAK6 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PAK6/PAK6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2640-Ab-1/ GM-Tg-hg-IP2640-Ab-2Anti-Human PAK6 monoclonal antibodyHuman
GM-Tg-rg-IP2640-Ab-1/ GM-Tg-rg-IP2640-Ab-2Anti-Rat PAK6 monoclonal antibodyRat
GM-Tg-mg-IP2640-Ab-1/ GM-Tg-mg-IP2640-Ab-2Anti-Mouse PAK6 monoclonal antibodyMouse
GM-Tg-cynog-IP2640-Ab-1/ GM-Tg-cynog-IP2640-Ab-2Anti-Cynomolgus/ Rhesus macaque PAK6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2640-Ab-1/ GM-Tg-felg-IP2640-Ab-2Anti-Feline PAK6 monoclonal antibodyFeline
GM-Tg-cang-IP2640-Ab-1/ GM-Tg-cang-IP2640-Ab-2Anti-Canine PAK6 monoclonal antibodyCanine
GM-Tg-bovg-IP2640-Ab-1/ GM-Tg-bovg-IP2640-Ab-2Anti-Bovine PAK6 monoclonal antibodyBovine
GM-Tg-equg-IP2640-Ab-1/ GM-Tg-equg-IP2640-Ab-2Anti-Equine PAK6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2640-Ab-1/ GM-Tg-hg-IP2640-Ab-2; GM-Tg-rg-IP2640-Ab-1/ GM-Tg-rg-IP2640-Ab-2;
GM-Tg-mg-IP2640-Ab-1/ GM-Tg-mg-IP2640-Ab-2; GM-Tg-cynog-IP2640-Ab-1/ GM-Tg-cynog-IP2640-Ab-2;
GM-Tg-felg-IP2640-Ab-1/ GM-Tg-felg-IP2640-Ab-2; GM-Tg-cang-IP2640-Ab-1/ GM-Tg-cang-IP2640-Ab-2;
GM-Tg-bovg-IP2640-Ab-1/ GM-Tg-bovg-IP2640-Ab-2; GM-Tg-equg-IP2640-Ab-1/ GM-Tg-equg-IP2640-Ab-2
Products NameAnti-PAK6 monoclonal antibody
Formatmab
Target NamePAK6
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PAK6 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2640-Ag-1Recombinant multi-species PAK6/ PAK5 protein
    ORF Viral VectorpGMLP004141human PAK6 Lentivirus plasmid
    ORF Viral VectorvGMLP004141human PAK6 Lentivirus particle


    Target information

    Target IDGM-IP2640
    Target NamePAK6
    Gene ID56924,214230,296078,701589,100856038,101091201,539224,100071463
    Gene Symbol and Synonyms4732456M09,PAK5,PAK6
    Uniprot AccessionQ9NQU5
    Uniprot Entry NamePAK6_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000137843
    Target ClassificationKinase

    The target: PAK6, gene name: PAK6, also named as PAK5. This gene encodes a member of a family of p21-stimulated serine/threonine protein kinases, which contain an amino-terminal Cdc42/Rac interactive binding (CRIB) domain and a carboxyl-terminal kinase domain. These kinases function in a number of cellular processes, including cytoskeleton rearrangement, apoptosis, and the mitogen-activated protein (MAP) kinase signaling pathway. The protein encoded by this gene interacts with androgen receptor (AR) and translocates to the nucleus, where it is involved in transcriptional regulation. Changes in expression of this gene have been linked to prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.